Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/25232064/ below:

Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis

Review

Affiliations

• ¹ Women's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK.
• ² Women's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK Clinical Biostatistics Unit, Hospital Ramon y Cajal (IRYCIS) and CIBER Epidemiologia y Salud Publica, Madrid, Spain javier.zamora@hrc.es.

• PMID: 25232064
• PMCID: PMC4166201
• DOI: 10.1136/bmj.g5264

Item in Clipboard

Review

Neha Pathak et al. BMJ. 2014.

• ¹ Women's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK.
• ² Women's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK Clinical Biostatistics Unit, Hospital Ramon y Cajal (IRYCIS) and CIBER Epidemiologia y Salud Publica, Madrid, Spain javier.zamora@hrc.es.

• PMID: 25232064
• PMCID: PMC4166201
• DOI: 10.1136/bmj.g5264

Item in Clipboard

Objective: To determine the accuracy of testing for human papillomavirus (HPV) DNA in urine in detecting cervical HPV in sexually active women.

Design: Systematic review and meta-analysis.

Data sources: Searches of electronic databases from inception until December 2013, checks of reference lists, manual searches of recent issues of relevant journals, and contact with experts.

Eligibility criteria: Test accuracy studies in sexually active women that compared detection of urine HPV DNA with detection of cervical HPV DNA.

Data extraction and synthesis: Data relating to patient characteristics, study context, risk of bias, and test accuracy. 2 × 2 tables were constructed and synthesised by bivariate mixed effects meta-analysis.

Results: 16 articles reporting on 14 studies (1443 women) were eligible for meta-analysis. Most used commercial polymerase chain reaction methods on first void urine samples. Urine detection of any HPV had a pooled sensitivity of 87% (95% confidence interval 78% to 92%) and specificity of 94% (95% confidence interval 82% to 98%). Urine detection of high risk HPV had a pooled sensitivity of 77% (68% to 84%) and specificity of 88% (58% to 97%). Urine detection of HPV 16 and 18 had a pooled sensitivity of 73% (56% to 86%) and specificity of 98% (91% to 100%). Metaregression revealed an increase in sensitivity when urine samples were collected as first void compared with random or midstream (P=0.004).

Limitations: The major limitations of this review are the lack of a strictly uniform method for the detection of HPV in urine and the variation in accuracy between individual studies.

Conclusions: Testing urine for HPV seems to have good accuracy for the detection of cervical HPV, and testing first void urine samples is more accurate than random or midstream sampling. When cervical HPV detection is considered difficult in particular subgroups, urine testing should be regarded as an acceptable alternative.

© Pathak et al 2014.

PubMed Disclaimer

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Fig 1 Study selection process

Fig 1 Study selection process

Fig 1 Study selection process

Fig 2 QUADAS-2 quality assessment of 14…

Fig 2 QUADAS-2 quality assessment of 14 studies included in meta-analysis

Fig 2 QUADAS-2 quality assessment of 14 studies included in meta-analysis

Fig 3 Receiver operating characteristic plots for…

Fig 3 Receiver operating characteristic plots for studies evaluating accuracy of detecting human papillomavirus (HPV)…

Fig 3 Receiver operating characteristic plots for studies evaluating accuracy of detecting human papillomavirus (HPV) in urine compared with in cervix

• Diagnostic Test Accuracy of First-Void Urine Human Papillomaviruses for Presence Cervical HPV in Women: Systematic Review and Meta-Analysis.

  Bober P, Firment P, Sabo J. Bober P, et al. Int J Environ Res Public Health. 2021 Dec 17;18(24):13314. doi: 10.3390/ijerph182413314. Int J Environ Res Public Health. 2021. PMID: 34948919 Free PMC article. Review.

• Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples.

  Van Keer S, Tjalma WAA, Pattyn J, Biesmans S, Pieters Z, Van Ostade X, Ieven M, Van Damme P, Vorsters A. Van Keer S, et al. Eur J Clin Microbiol Infect Dis. 2018 May;37(5):859-869. doi: 10.1007/s10096-017-3179-1. Epub 2018 Feb 7. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29417310 Free PMC article.

• Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.

  Ducancelle A, Legrand MC, Pivert A, Veillon P, Le Guillou-Guillemette H, De Brux MA, Beby-Defaux A, Agius G, Hantz S, Alain S, Catala L, Descamps P, Postec E, Caly H, Charles-Pétillon F, Labrousse F, Lunel F, Payan C. Ducancelle A, et al. Arch Gynecol Obstet. 2014 Aug;290(2):299-308. doi: 10.1007/s00404-014-3191-y. Epub 2014 Mar 13. Arch Gynecol Obstet. 2014. PMID: 24622934

• Urine testing for HPV: rationale for using first void.

  Vorsters A, Van Damme P, Clifford G. Vorsters A, et al. BMJ. 2014 Oct 15;349:g6252. doi: 10.1136/bmj.g6252. BMJ. 2014. PMID: 25319476 No abstract available.

• The diagnostic value of serum hybrid capture 2 (CH2) HPV DNA in cervical cancer: a systematic review and meta-analysis.

  Yin D, Jiang Y, Wang N, Ouyang L, Lu Y, Zhang Y, Wei H, Zhang S. Yin D, et al. Tumour Biol. 2014 Sep;35(9):9247-53. doi: 10.1007/s13277-014-2214-4. Epub 2014 Jun 17. Tumour Biol. 2014. PMID: 24935474 Review.

• An outreach strategy to increase uptake of vaginal self-sampling for cervical cancer screening in older French women: The RIDECA interventional research protocol.

  Lareyre O, Mollevi C, Broc G, Caspar MN, Pehlivanska G, Boyer H, Groc S, Corradi G, Loy-Morel S, Guy M, Tricheux N, Cousson-Gélie F, Boulle N. Lareyre O, et al. Womens Health (Lond). 2024 Jan-Dec;20:17455057241292693. doi: 10.1177/17455057241292693. Womens Health (Lond). 2024. PMID: 39474856 Free PMC article.

• Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine.

  Pattyn J, Van Keer S, Téblick L, Van Damme P, Vorsters A. Pattyn J, et al. Front Immunol. 2020 Aug 5;11:1657. doi: 10.3389/fimmu.2020.01657. eCollection 2020. Front Immunol. 2020. PMID: 32849573 Free PMC article.

• Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).

  Stanczuk G, Baxter G, Currie H, Lawrence J, Cuschieri K, Wilson A, Arbyn M. Stanczuk G, et al. BMJ Open. 2016 Apr 25;6(4):e010660. doi: 10.1136/bmjopen-2015-010660. BMJ Open. 2016. PMID: 27113237 Free PMC article.

• Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.

  Shin HY, Lee B, Hwang SH, Lee DO, Sung NY, Park JY, Jun JK. Shin HY, et al. J Gynecol Oncol. 2019 Sep;30(5):e76. doi: 10.3802/jgo.2019.30.e76. J Gynecol Oncol. 2019. PMID: 31328458 Free PMC article.

• Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

  Arbyn M, Smith SB, Temin S, Sultana F, Castle P; Collaboration on Self-Sampling and HPV Testing. Arbyn M, et al. BMJ. 2018 Dec 5;363:k4823. doi: 10.1136/bmj.k4823. BMJ. 2018. PMID: 30518635 Free PMC article.

1. 1. Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T, et al. Clinician’s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis 2009;9:347-56. - PubMed
2. 1. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121:621-32. - PubMed
3. 1. Trent Cancer Registry. Profile of cervical cancer in england: incidence, mortality and survival. National Cancer Intelligence Network, 2012.
4. 1. National Cancer Intelligence Network. Cervical cancer incidence and screening coverage. 2014. www.ncin.org.uk/publications/data_briefings/cervical_incidence_and_scree....
5. 1. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72. - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3